Elixir Bio-Tech is a biotech products manufacturing company.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Las Cruces
State: New Mexico
Zip:
Country: United States
Elixir Bio-Tech is launching the ‘Algae Industrial Park’ on 320 acres in Sierra County, NM, showcasing patented &a; proprietary Closed &a; Greenhouse bioreactor systems that produce Algae multi-purpose Biomass to Nutraceuticals, Pharmaceuticals &a; Biofuels. Currently in high demand, scarce supply within the Health &a; Wellness &a; Biofuel markets. The Algae Industry is a rapid growth industry. Large investors include: the DOE/USDA, billions, $600M each: Exxon Mobll, Chevron, Royal Dutch Shell, &a; Phillips Petroleum in NM, alongside Bill Gates $150M in NM. The Company&s;s key managers are experienced in Algae Engineering &a; Technology along with NM&s;s Santa Fe Community College&s;s (SFCC’s) Biofuel program &a; other collaborators to advance Algoculture methods in the emerging Algae frontier. Similar to the advent of corn, Algae Nutraceuticals &a; Biofuels address the many critical problems, crucial in the life &a; health sciences from malnutrition, hunger, Aids, chronic disorders to radiation sickness, CO2 reduction, Water recycling to renewable fuels. New Mexico’s climate is ideal for Algae farming year round. This project is strategically located just 6 miles from Spaceport America housing Virgin Galactica, &a; Space X. with possible biofuel contracts. Phase 1: immediate capital raise: $1M Algae Industrial Park property acquisition as collateral, loan/equity options; provides product flow buy/sell bulk &a; packaged algae products under offtake agreements to meet sales timelines &a; benchmark accomplishments in year 1. Phase 2: Interim $5M pre-opening operating budget can be augmented by USDA REAP loan which provides post-application funding for land acquisition, working capital, construction, buildings, machinery, equipment &a; professional services: 80% guarantee; 20% company, lenders or investors. ROI is projected at 25% in year 2. Elixir Bio-Tech&s;s PPM is valued at $50M, under Regulation D Sec. Rule 506 for private investors; covers total project requirements over a 3 year period.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2014 | Convertible Note | $250k |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|